Coronary Artery Disease and Sleep Apnea

The purpose of this study is to determine the effect of sleep apnea on mortality, stroke and myocardial infarction among 408 patients with coronary artery disease referred for evaluation of coronary intervention who were examined with overnight cardio respiratory monitoring between March 1992 and June 1995.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Artery Disease Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Disease Heart Diseases Myocardial Ischemia Vascular Diseases

Age range

Up to 70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept of Cardiology

Umeå, SE 901 85, Sweden

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Men and women younger than 70 with disabling angina pectoris and coronary disease according to coronary angiography.

Treatment and study plan

There is no intervention

Other

Primary outcomes

Stroke, death, acute myocardial infarction

Time frame: 10 years from date of inclusion

Interested in participating?

Completed

Looking for future studies?

Notify Me

Sponsors and collaborators

Lead sponsor

Umeå University

Other

Collaborators

Jämtland County Council, Sweden
Norrländska Hjärtfonden
Swedish Heart Lung Foundation

Registry information

Official study title

Long Term Effects of Sleep Apnea in Patients With Coronary Artery Disease

Important dates

Study start: 1992
Study completion: 2007
First posted: Nov 22, 2007
Registry last updated: Jul 2, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed